This federal contract award, valued at $5,775.00, was issued by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a period of performance from September 23, 2024, to September 26, 2024, and is structured as a Delivery Order under a fixed-price with economic price adjustment pricing type. This award does not have a set-aside designation, indicating that Arthrex competed in the open market for this contract. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida, and has secured numerous federal contracts with agencies such as the Department of Veterans Affairs (VA) and the Department of Defense (DoD) to provide a wide range of innovative orthopedic solutions, including surgical implants, instruments, and biologics.
Generated 12/23/24, 2:29 PM